UK markets open in 57 minutes
NIKKEI 225
38,785.49 -137.51 (-0.35%) HANG SENG
18,472.83 +69.83 (+0.38%) CRUDE OIL
73.39 -0.83 (-1.12%) GOLD FUTURES
2,367.90 -1.40 (-0.06%) DOW
38,571.03 -115.27 (-0.30%) Bitcoin GBP
53,852.03 +210.89 (+0.39%)
Ovid Therapeutics Inc. (OVID)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.0600 |
| Open | 3.0900 |
| Bid | 3.0000 x 200 |
| Ask | 3.0400 x 100 |
| Day's range | 3.0000 - 3.1300 |
| 52-week range | 2.5700 - 4.1390 |
| Volume | |
| Avg. volume | 189,600 |
| Market cap | 214.253M |
| Beta (5Y monthly) | 0.69 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
Ovid Therapeutics (OVID) delivered earnings and revenue surprises of 26.09% and 40.95%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Beam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Beam Therapeutics (BEAM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Ovid Therapeutics (OVID) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.